We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Quad
QUAD
$559M
| $31K | ﹤0.01% |
1,357
+198
| +17% | +$4.71K |
|
652
Revvity
RVTY
$12.9B
| $31K | ﹤0.01% |
459
+31
| +7% | +$1.93K |
|
653
AngioDynamics
ANGO
$627M
| $30K | ﹤0.01% |
1,836
+72
| +4% | +$1.14K |
|
654
CMS Energy
CMS
$22.5B
| $30K | ﹤0.01% |
644
-13,403
| -95% | -$620K |
|
655
Koppers
KOP
$976M
| $30K | ﹤0.01% |
833
+296
| +55% | +$11.4K |
|
656
Boston Beer
SAM
$1.94B
| $30K | ﹤0.01% |
224
+58
| +35% | +$8.11K |
|
657
Sanmina
SANM
$10.4B
| $30K | ﹤0.01% |
796
-157
| -16% | -$5.96K |
|
|
SPR
658
DELISTED
Spirit AeroSystems
SPR
| $30K | ﹤0.01% |
520
+80
| +18% | +$4.49K |
|
659
Xerox
XRX
$411M
| $30K | ﹤0.01% |
1,030
+496
| +93% | +$14K |
|
|
ETFC
660
DELISTED
E*Trade Financial Corporation
ETFC
| $30K | ﹤0.01% |
791
+56
| +8% | +$1.98K |
|
|
SHLM
661
DELISTED
Schulman (A.) Inc
SHLM
| $30K | ﹤0.01% |
+953
| New | +$28.3K |
|
|
PRXL
662
DELISTED
Parexel International Corp
PRXL
| $30K | ﹤0.01% |
340
-204
| -38% | -$15.2K |
|
663
Amkor Technology
AMKR
$12.6B
| $29K | ﹤0.01% |
2,961
+579
| +24% | +$6.56K |
|
664
Integra LifeSciences
IART
$1.39B
| $29K | ﹤0.01% |
529
-191
| -27% | -$9.12K |
|
665
VeriSign
VRSN
$27B
| $29K | ﹤0.01% |
316
+26
| +9% | +$2.35K |
|
|
CLGX
666
DELISTED
Corelogic, Inc.
CLGX
| $29K | ﹤0.01% |
664
+32
| +5% | +$1.35K |
|
667
Akamai
AKAM
$17.1B
| $28K | ﹤0.01% |
556
-82,061
| -99% | -$4.33M |
|
668
Charles River Laboratories
CRL
$11.1B
| $28K | ﹤0.01% |
272
+17
| +7% | +$1.56K |
|
669
Federated Hermes
FHI
$4.77B
| $28K | ﹤0.01% |
977
+101
| +12% | +$2.7K |
|
670
NetApp
NTAP
$35.9B
| $28K | ﹤0.01% |
709
+98
| +16% | +$3.91K |
|
671
Nu Skin
NUS
$251M
| $28K | ﹤0.01% |
447
+28
| +7% | +$1.6K |
|
672
Oshkosh
OSK
$9.16B
| $28K | ﹤0.01% |
411
+43
| +12% | +$2.9K |
|
673
Teradata
TDC
$3.24B
| $28K | ﹤0.01% |
937
+104
| +12% | +$3.04K |
|
|
CTXS
674
DELISTED
Citrix Systems Inc
CTXS
| $28K | ﹤0.01% |
347
+57
| +20% | +$4.72K |
|
675
Amphastar Pharmaceuticals
AMPH
$892M
| $27K | ﹤0.01% |
1,514
+269
| +22% | +$4.27K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.